Detalles de la búsqueda
1.
Early Tumor Shrinkage and Depth of Response as Predictors of Survival for Advanced Biliary Tract Cancer: An Exploratory Analysis of JCOG1113.
Oncologist;
29(1): e97-e107, 2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37531645
2.
Multicenter validation study of a treatment selection MAP for pancreatic neuroendocrine tumors.
Jpn J Clin Oncol;
2024 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38677983
3.
Current status of the cost burden of first-line systemic treatment for patients with advanced hepatocellular carcinoma in Japan, 2021-22.
Jpn J Clin Oncol;
2024 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38843879
4.
Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer.
Br J Cancer;
128(8): 1603-1608, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36782009
5.
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study).
Br J Cancer;
129(6): 1032-1039, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37532830
6.
A prospective multicenter phase II study of FOLFIRINOX as a first-line treatment for patients with advanced and recurrent biliary tract cancer.
Invest New Drugs;
41(1): 76-85, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36459291
7.
Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study.
Gastric Cancer;
26(6): 1020-1029, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37610558
8.
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study.
Hepatol Res;
53(5): 409-416, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36601972
9.
Comprehensive review of undifferentiated carcinoma of the pancreas: from epidemiology to treatment.
Jpn J Clin Oncol;
53(9): 764-773, 2023 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37325968
10.
Effect of systemic inflammatory response on induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancer: an exploratory subgroup analysis on systemic inflammatory response in JCOG1106.
Jpn J Clin Oncol;
53(8): 704-713, 2023 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37248668
11.
Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic Cancer.
Oncologist;
27(10): e774-e782, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35946841
12.
Efficacy of chemotherapy for patients with metastatic or recurrent pancreatic adenosquamous carcinoma: A multicenter retrospective analysis.
Pancreatology;
22(8): 1159-1166, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36150984
13.
Multicenter phase II trial of trastuzumab deruxtecan for HER2-positive unresectable or recurrent biliary tract cancer: HERB trial.
Future Oncol;
18(19): 2351-2360, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35510484
14.
Endoscopic duodenal stent placement versus gastrojejunostomy for unresectable pancreatic cancer patients with duodenal stenosis before introduction of initial chemotherapy (GASPACHO study): a multicenter retrospective study.
Jpn J Clin Oncol;
52(2): 134-142, 2022 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34969090
15.
Multicenter Phase II Trial of Axitinib Monotherapy for Gemcitabine-Based Chemotherapy Refractory Advanced Biliary Tract Cancer (AX-BC Study).
Oncologist;
26(2): 97-e201, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33010112
16.
Randomized phase II study of chemoradiotherapy with versus without induction chemotherapy for locally advanced pancreatic cancer: Japan Clinical Oncology Group trial, JCOG1106.
Jpn J Clin Oncol;
51(2): 235-243, 2021 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33164066
17.
First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumors.
Invest New Drugs;
38(5): 1495-1506, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32198649
18.
FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer: A subset analysis of data from a nationwide multicenter observational study in Japan.
Pancreatology;
20(7): 1519-1525, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32972834
19.
Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study).
Int J Clin Oncol;
25(10): 1835-1843, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32535711
20.
Impact of UGT1A1 genetic polymorphism on toxicity in unresectable pancreatic cancer patients undergoing FOLFIRINOX.
Cancer Sci;
110(2): 707-716, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30447099